Long-term results after mitral valve repair in children

Lee, Cheul; Lee, Chang-Ha; Kwak, Jae Gun; Park, Chun Soo; Kim, Soo-Jin; Song, Jin Young; Shim, Woo-Sup
February 2010
European Journal of Cardio-Thoracic Surgery;Feb2010, Vol. 37 Issue 2, p267
Academic Journal
Abstract: Objective: We analysed the long-term results of mitral valve (MV) repair in children. Methods: We reviewed clinical records of 139 children (<18 years) who underwent MV repair between 1988 and 2007. Patients with atrioventricular septal defect, single ventricle or atrioventricular discordance were excluded. Median age was 2.3 years (2 months to 17.6 years), and 47 children (34%) were infants. Mitral regurgitation (MR) was predominant in 125 patients (90%), and 91 (73%) of these showed MR grade ≥3. Mitral stenosis (MS) was predominant in 14 patients (10%), and median mean pressure gradient across the MV was 9.0mmHg (0–20mmHg). Associated cardiac lesions were present in 111 patients (80%) and were addressed concurrently in 105 patients. Various surgical techniques were used according to the functional and pathologic findings of MV. Results: There was no early death. Median follow-up was 8 years (2 months to 20 years, 78% complete). Twenty-six patients required 29 MV re-operations, and 11 of these required MV replacements. At 15 years, freedom from MV re-operation and MV replacement was 77% and 90%, respectively. Diagnosis of MS and MV status on discharge (MR grade ≥3 or MS gradient ≥10mmHg) were significant risk factors for re-operation. There were three late deaths, and the overall survival was 97% at 15 years. Among 122 survivors with MR, 102 patients (84%) underwent echocardiography during follow-up. The degree of MR decreased significantly and only five patients showed MR grade 3. Among 14 survivors with MS, eight patients (57%) underwent echocardiography during follow-up. The degree of MS decreased significantly and median MS gradient was 2.8mmHg (0–10mmHg). All survivors remain in the NYHA class I or II. Conclusions: MV repair in children showed excellent survival, acceptable re-operation rate and satisfactory valve function at long-term follow-up. Residual MV dysfunction was a significant risk factor for re-operation, but re-repair was successful in more than half of the patients who underwent re-operation.


Related Articles

  • Monocuspidalisation of the mitral valve can be a solution for ischemic mitral regurgitation. Büyükbayrak, Fuat; Adademir, Taylan; Kaymaz, Cihangir; Alp, Mete // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;May2014, Vol. 14 Issue 3, p311 

    A letter to the editor is presented offering information related to the use of monocuspidalisation of the mitral valve for ischemic mitral regurgitation.

  • Editorial Comment: Mitral valve repair for atrial functional mitral valve regurgitation due to atrial fibrillation. Anyanwu, Anelechi C. // European Journal of Cardio-Thoracic Surgery;Oct2012, Vol. 42 Issue 4, p638 

    The article presents information regarding the atria functional mitral valve regurgitation by repairing of mitral valve in the condition of atrial fibrillation. It presents information on a research that reported 20 patients undergoing mitral valve repair with ring annuloplasty. It mentions that...

  • Valve disease: diagnosing normal and abnormal heart functioning. Keenan, Jan // British Journal of Healthcare Assistants;Feb2011, Vol. 5 Issue 2, p74 

    Heart valves are complex, sophisticated structures. In order for healthcare assistants and assistant practitioners to care for those with valve disease, they must be able to understand the basic physiology of this condition. Valve disease can be a challenge to recognize and manage, but accurate...

  • Surgical revision after percutaneous mitral valve repair by edge-to-edge device: when the strategy fails in the highest risk surgical population. Alozie, Anthony; Westphal, Bernd; Kische, Stephan; Kaminski, Alexander; Paranskaya, Liliya; Bozdag-Turan, Ilkay; Ortak, Jasmin; Schubert, Jochen; Steinhoff, Gustav; Ince, Hüseyin // European Journal of Cardio-Thoracic Surgery;Jul2014, Vol. 46 Issue 1, p55 

    OBJECTIVES Percutaneous edge-to-edge devices for non-surgical repair of mitral valve regurgitation are under clinical evaluation in high-risk patients deemed not suitable for conventional surgery. To address guidelines for initial therapy decision, we here report on 13 cases of surgery after...

  • Editorial Comment: Secondary mitral regurgitation in patients undergoing aortic valve replacement. De Bonis, Michele; Lapenna, Elisabetta; Giacomini, Andrea; Alfieri, Ottavio // European Journal of Cardio-Thoracic Surgery;Jul2013, Vol. 44 Issue 1, p40 

    The article discusses the significance of secondary mitral regurgitation (MR) in patients undergoing aortic valve replacement. It mentions that mitral valve (MV) surgery should be performed when severe functional MR exists. It adds that the presence of myocardial revascularization and the use of...

  • Evalve treats 1st patients at Swedish hospital.  // Medical Device Daily;8/25/2009, Vol. 13 Issue 163, p7 

    The article reports on the successful treatment of a group of patients who are suffering from the effects of functional and degenerative mitral regurgitation (MR) using Evalve's MitralClip system in Sweden. Evalve claims that MitralClip is the only medical device available in the European Union...

  • Left atrial spontaneous echo contrast and thrombus formation at septal puncture during percutaneous mitral valve repair with the MitraClip system of severe mitral regurgitation: a report of two cases. Bilge, Mehmet; Yaşar, Ayşe Saatcı; Ali, Sina; Alemdar, Recai // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Sep2014, Vol. 14 Issue 6, p549 

    The article presents two case studies including one of a 75-year-old man with atrial fibrillation and mitral regurgitation (MR) and one of a 43-year-old man with a left ventricular ejection fraction of 15 percent. Transesophageal echocardiography of the patients revealed severe MR. Both were...

  • Transcatheter mitral valve implantation via transapical approach: an early experience. Sondergaard, Lars; Brooks, Matthew; Ihlemann, Nikolaj; Jonsson, Anders; Holme, Susanne; Tang, Mariann; Terp, Kim; Quadri, Arshad // European Journal of Cardio-Thoracic Surgery;Dec2015, Vol. 48 Issue 6, p873 

    OBJECTIVES: As many as 50% of patients with severe symptomatic mitral valve regurgitation are denied surgical valve replacement or repair due to high operative risk. We describe an early series of cases of transcatheter implantation with a CardiAQâ„¢ mitral valve via a transapical approach....

  • Mitralign Raises $35 Mln Series D Financing.  // Biomedical Market Newsletter;5/18/2012, Vol. 21, p1 

    The article provides information on the announcement made by Mitralign Inc., regarding the closing of a 35 million U.S. dollar Series D round of funding led by the company Forbion Capital Partners, a capital investor of the company. Mitralign is the developer of the only percutaneous direct...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics